Delivery Order SPE2DB22D3016-SPE2DB24FBAZ3
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$2.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,213.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML, a pharmaceutical product. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award, valued at $1,961.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of the pharmaceutical product Granix 480 mcg Tbo. This contract is not set aside and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to...
This federal contract award, issued by the Defense Logistics Agency (DLA), was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,698.53 firm fixed-price delivery order is for the supply of Granix 300 mcg TBO, a specialty medication. The contract has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4,565,096,500 units of the pharmaceutical product GRANIX 480 MCG/0.8 ML SAFE SYR 0.8ML. The contract has a firm fixed price of $8,824.41 and a completion date of July 10, 2024. This is a delivery order contract, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML. The contract is a Firm Fixed Price Delivery Order valued at $7,214.20 and has an ultimate completion date of August 2, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML, a pharmaceutical product. The contract has a ceiling value of $1,240.72 and is structured as a firm fixed price delivery order, with an ultimate completion date of June 11, 2025. The contract is not set aside for any specific business type....
This is a $2,138.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GRANIX 300 MCG/0.5 ML SAFE SYR 0.5ML, a pharmaceutical product, with a period of performance through May 29, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FEVH0, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of GRANIX 300 MCG/ML VIALML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,231.44 and an ultimate completion date of June 5, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) with a delivery order valued at $1,443.79. The contract has a period of performance through March 12, 2024 and is a firm fixed-price delivery order, without any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of pharmaceutical products and medical supplies to the U.S. government. The $1,442.40 firm-fixed-price Delivery Order is awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). This award is not associated with any set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00...